Pedro Ávila- Ribeiro

GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis

R. Ribeiro, F. Pimentel-Santos, A. Rodrigues, 2020, Annals of the rheumatic diseases.